Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has informed the exchanges that its trading window for dealing in company securities will remain closed starting October 1, 2025. The closure will stay in effect until 48 hours after the company announces its unaudited financial results for the quarter and half year ending September 30, 2025. The restriction applies to all designated persons and their immediate relatives under the company's insider trading code. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, ahead of the upcoming Q2 and H1 FY26 earnings announcement. The date of the board meeting to approve these results will be communicated separately.
This is a standard regulatory disclosure with no direct impact on shareholders. It signals that Q2 FY26 financial results are imminent, which investors should watch for as they could influence short-term stock movement.